{"schema_version":"secwatch.filing_event.v1","accession":"0001453687-26-000100","form_type":"8-K","ticker":"RNAC","cik":"0001453687","company_name":"Cartesian Therapeutics, Inc.","filed_at":"2026-08-06T11:03:44+00:00","discovered_at":"2026-08-06T11:05:00.260856+00:00","generated_at":"2026-08-06T11:06:34.111361+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cartesian Therapeutics Q2 2026 net income $15.8M; cash $149.3M; Phase 3 AURORA data expected 1Q27","bullets":["Net income $15.8M ($0.47 basic EPS) vs $15.9M prior year; R&D expenses $20.4M, G&A $8.7M.","Cash $149.3M as of June 30, 2026; cash runway into 2028 via up to $150M K2HV credit facility (first $50M funded).","Phase 3 AURORA trial of Descartes-08 in MG on track; data expected 1Q27, BLA filing mid-2027.","Phase 2 TRITON myositis data subset expected 1H27; Phase 1/2 HELIOS pediatric JDM data expected 1H27.","New licensing agreement with WestGene for in vivo CAR-T; Phase 1 trial 2H26 with data 1H27."],"urls":{"canonical":"https://secwatch.observer/filing/0001453687-26-000100","json":"https://secwatch.observer/filing/0001453687-26-000100.json","markdown":"https://secwatch.observer/filing/0001453687-26-000100.md","text":"https://secwatch.observer/filing/0001453687-26-000100.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453687/000145368726000100/0001453687-26-000100-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453687/000145368726000100/rnac-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T11:06:34.111361+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}